Myosin Therapeutics Awarded $3 Million NIH Grant To Advance Clinical Trial for MT-110 in Methamphetamine Use Disorder
UF Startup Myosin Therapeutics, Inc., a biotechnology company developing innovative therapies for cancer and neurological disorders, announced that it has been awarded a $3 million grant from NIDA, part of NIH.
UF Researchers Demonstrate GLP-1RAs’ Potential To Treat Depression
UF researchers have found that GLP-1RAs, a class of glucose-lowering medications, may have antidepressant effects in a study funded by the NIH.
UF College of Medicine’s 2024 NIH-Funded Research Makes an Impact in Neurological Disease, Cancer, Diabetes and More
UF researchers have led significant projects, funded by the National Institutes of Health, to enhance the lives of current and future patients affected by a wide range of medical conditions.
New Funding Secured To Support Clinical GMP Manufacturing Expansion at Rise Therapeutics
UF Startup Rise Therapeutics announced that it has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institute of Health (NIH).